Anagenics Ltd Q4 FY2026 Activity Report
Key points
- Improved operational performance with positive trading
- Cash outflows reduced to $0.08 million in Q4 FY2026
- Expects to announce maiden full-year profit for FY26
Full summary
Anagenics Ltd (ASX: AN1) has released its Q4 FY2026 activity report, highlighting improved operational performance and positive trading results. The company reported operating cash outflows of $0.08 million for the quarter, significantly lower than the $1.6 million in the previous year. The reduction in cash outflows was driven by the resolution of outstanding creditor payments following a restructuring. The company also reported $446k in royalty revenue from the YSB product line, with total YSB royalty revenue invoiced at $1.3 million for the year. Anagenics expects to announce its maiden full-year profit for FY26, subject to the final audit.
Guidance
Operating Cash Outflows reduced to $0.08 million in Q4 FY2026, down from $1.6 million in Q4 FY2025
Outlook
Anagenics expects to announce its maiden full-year profit for FY26, subject to the final audit.
Summary generated by a large language model. Please interpret with care.